164
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Discordant Quantitative and Visual CT Assessments in the Diagnosis of Emphysema

ORCID Icon, , & ORCID Icon
Pages 1231-1242 | Published online: 03 May 2021

References

  • Lynch DA, Austin JH, Hogg JC, et al. CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner society. Radiology. 2015;277(1):192–205. doi:10.1148/radiol.2015141579
  • Barr RG, Berkowitz EA, Bigazzi F, et al. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012;9(2):151–159. doi:10.3109/15412555.2012.654923
  • Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32–43. doi:10.3109/15412550903499522
  • COPDGene. Clinical center manual of procedures. Version 5.0; 2009. Available from: www.copdgene.org/sites/default/files/COPDGene%20MOP%2006.19.2009.pdf. Accessed February 11, 2021.
  • Wan ES, Hokanson JE, Murphy JR, et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med. 2011;184(1):57–63. doi:10.1164/rccm.201101-0021OC
  • Wan ES, Castaldi PJ, Cho MH, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15:89. doi:10.1186/s12931-014-0089-y
  • Lowe KE, Regan EA, Anzueto A, et al. COPDGene((R)) 2019: redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis. 2019;6(5):384–399.
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108
  • Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS workshop on lung volume measurements. Official statement of the European respiratory society. Eur Respir J. 1995;8(3):492–506. doi:10.1183/09031936.95.08030492
  • Brecthel L, Gainey J, Penwell A, Nathaniel TI. Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients. BMC Neurol. 2018;18(1):215. doi:10.1186/s12883-018-1204-3
  • Fortis S, Comellas A, Make BJ, et al. Combined forced expiratory volume in 1 second and forced vital capacity bronchodilator response, exacerbations, and mortality in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2019;16(7):826–835. doi:10.1513/AnnalsATS.201809-601OC
  • Fortis S, Eberlein M, Georgopoulos D, Comellas AP. Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes. BMJ Open Respir Res. 2017;4(1):e000213. doi:10.1136/bmjresp-2017-000213
  • Burns RJ, Deschenes SS, Schmitz N. Associations between depressive symptoms and social support in adults with diabetes: comparing directionality hypotheses with a longitudinal cohort. Ann Behav Med. 2016;50(3):348–357. doi:10.1007/s12160-015-9760-x
  • Park J, Hobbs BD, Crapo JD, et al. Subtyping COPD by using visual and quantitative CT imaging features. Chest. 2019;157(1):47–60.
  • Hoffman EA, Ahmed FS, Baumhauer H, et al. Variation in the percent of emphysema-like lung in a healthy, nonsmoking multiethnic sample. The MESA lung study. Ann Am Thorac Soc. 2014;11(6):898–907. doi:10.1513/AnnalsATS.201310-364OC
  • Tam A, Morrish D, Wadsworth S, Dorscheid D, Man SF, Sin DD. The role of female hormones on lung function in chronic lung diseases. BMC Womens Health. 2011;11:24. doi:10.1186/1472-6874-11-24
  • Pompe E, van Rikxoort EM, Schmidt M, et al. Parametric response mapping adds value to current computed tomography biomarkers in diagnosing chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(9):1084–1086. doi:10.1164/rccm.201411-2105LE
  • Pompe E, Galban CJ, Ross BD, et al. Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease. Respir Med. 2017;123:48–55. doi:10.1016/j.rmed.2016.11.021
  • Labaki WW, Gu T, Murray S, et al. Voxel-wise longitudinal parametric response mapping analysis of chest computed tomography in smokers. Acad Radiol. 2019;26(2):217–223. doi:10.1016/j.acra.2018.05.024
  • Edge J, Simon G, Reid L. Peri-acinar (paraseptal) emphysema: its clinical, radiological, and physiological features. Br J Dis Chest. 1966;60(1):10–18. doi:10.1016/S0007-0971(66)80016-5
  • Smith BM, Austin JH, Newell JD Jr, et al. Pulmonary emphysema subtypes on computed tomography: the MESA COPD study. Am J Med. 2014;127(1):94 e97. doi:10.1016/j.amjmed.2013.09.020
  • Araki T, Nishino M, Zazueta OE, et al. Paraseptal emphysema: prevalence and distribution on CT and association with interstitial lung abnormalities. Eur J Radiol. 2015;84(7):1413–1418. doi:10.1016/j.ejrad.2015.03.010
  • Mouronte-Roibas C, Fernandez-Villar A, Ruano-Ravina A, et al. Influence of the type of emphysema in the relationship between COPD and lung cancer. Int J Chron Obstruct Pulmon Dis. 2018;13:3563–3570. doi:10.2147/COPD.S178109
  • Galban CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18(11):1711–1715. doi:10.1038/nm.2971